Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2004 054 765.4 |
| 96 | EP file number | EAKZ | 14 17 9642.5 |
| 97 | EP publication number | EPN | 2815748 |
| 54 | Designation/title | TI | Verbindungen, Formulierungen und Verfahren zur Behandlung oder Vorbeugung von Rosacea |
| 51 | IPC main class | ICM
(ICMV) | A61K 31/137 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/4164 (2006.01), A61K 31/498 (2006.01), A61K 31/4174 (2006.01), A61K 45/06 (2006.01), A61P 17/10 (2006.01), A61P 17/00 (2006.01) |
| 22 | DE application date | DAT | May 26, 2004 |
| 96 | EP application date | EAT | May 26, 2004 |
| 43 | Date of first publication | OT | Dec 24, 2014 |
| Date of publication of grant | PET | Aug 5, 2020 |
| 71/73 | Applicant/owner | INH | Galderma Pharma S.A., Lausanne, CH |
| 72 | Inventor | IN | DeJovin, Jack A., New Brunswick, NJ New Jersey 08901, US; Rossi, Thomas, M., Stockton, NJ New Jersey 08559, US |
| Address for service | | V.O., 2508 DH The Hague, NL |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
473611 P
May 27, 2003
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
853585
May 25, 2004
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002815748
Searchable text:
EP000002815748
Original document:
EP000002815748B1
Searchable text:
EP000002815748B1 |
| 43 | Date of first publication | EVT | Dec 24, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Feb 7, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | May 28, 2024
(Show all update days)(Hide all update days)- Feb 7, 2015
- Date of the first transfer into DPMAregister
|
